Optimal time for the resumption of biologics after COVID-19
Saved in:
Main Authors: | Chia Siang Kow, MPharm (Author), Syed Shahzad Hasan, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacist-patient communication amid COVID-19 pandemic: A review of available options and potential impact
by: Chia Siang Kow, et al.
Published: (2021) -
Favipiravir and hyperuricemia in patients with COVID-19-suggestions for future studies
by: Chia Siang Kow, et al.
Published: (2023) -
Coenzyme Q10 therapy in patients with post COVID-19 condition
by: Chia Siang Kow, et al.
Published: (2023) -
Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?
by: Syed Shahzad Hasan, et al.
Published: (2020) -
Resumption of dental practice after COVID-19 lockdown: perspectives of dental professionals in Karachi, Pakistan
by: Sumaiya Zafar, et al.
Published: (2024)